Boston Scientific
BSX
1,317 hedge funds and large institutions have $102B invested in Boston Scientific in 2024 Q2 according to their latest regulatory filings, with 171 funds opening new positions, 551 increasing their positions, 418 reducing their positions, and 53 closing their positions.
223% more first-time investments, than exits
New positions opened: 171 | Existing positions closed: 53
33% more funds holding in top 10
Funds holding in top 10: 27 → 36 (+9)
32% more repeat investments, than reductions
Existing positions increased: 551 | Existing positions reduced: 418
13% more capital invested
Capital invested by funds: $90.8B → $102B (+$11.4B)
8% more funds holding
Funds holding: 1,222 → 1,317 (+95)
0.1% less ownership
Funds ownership: 90.38% → 90.27% (-0.1%)
3% less call options, than puts
Call options by funds: $729M | Put options by funds: $754M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vontobel Holding
Zurich,
Switzerland
|
+$568M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$322M |
| 3 |
Amundi
Paris,
France
|
+$318M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$273M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$264M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$1.08B |
| 2 |
JP Morgan Chase
New York
|
-$360M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$185M |
| 4 |
DCP
DSM Capital Partners
Palm Beach Gardens,
Florida
|
-$159M |
| 5 |
Holocene Advisors
New York
|
-$128M |
BSX Hedge Fund Activity: Q2 2024 in Review
1,317 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q2 2024, worth a combined $102B — up 13% from $90.8B a quarter earlier.
Buyers outnumbered sellers: 171 funds opened new BSX positions and 53 closed out — a net gain of 118 holders — while 551 added to existing stakes and 418 trimmed.
The largest buyer was Vontobel Holding, adding an estimated $568M. The largest seller was Massachusetts Financial Services, cutting an estimated $1.08B.
- 1,317 institutional investors held Boston Scientific (BSX) as of Q2 2024, up from 1,222 in Q1 2024.
- Funds reported $102B of Boston Scientific stock for Q2 2024, up 13% quarter-over-quarter.
- 171 funds opened new Boston Scientific positions in Q2 2024 and 53 closed out, a net change of +118 holders.
- The largest Boston Scientific buyer in Q2 2024 was Vontobel Holding, an estimated $568M added.
- The largest Boston Scientific seller in Q2 2024 was Massachusetts Financial Services, an estimated $1.08B sold.
Based on aggregated 13F filings for Q2 2024.